Merav Bar, MD
Patient Care Philosophy:
To work closely with each patient to design individualized treatment plans that meet the patient’s goals, and may incorporate innovative therapies found at our center.
Title
- Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center
- Assistant Professor, Medical Oncology Division, University of Washington
Clinical Expertise
Stem cell transplant, hematologic malignancies
Education And Training
- MD: Hebrew University
- Residency: University of Washington School of Medicine
- Fellowship: University of Washington School of Medicine
Clinical Trials
Dr. Bar is the SCCA lead investigator for the following clinical trials:
- Adoptive Immunotherapy for Relapsed AML, MDS, or CML (FH 2498)
- Brentuximab Vedotin for Steroid-Resistant Acute GVHD (FH 2589)